A Dlugosz, A Janecka - Current pharmaceutical design, 2016 - ingentaconnect.com
Cancer is one of the leading causes of mortality in the developed countries. The search for novel drug candidates is a priority goal for cancer therapy. However, the emergence of drug …
H Glavinas, P Krajcsi, J Cserepes… - Current drug …, 2004 - ingentaconnect.com
ATP Binding Cassette (ABC) transporters form a special family of membrane proteins, characterized by homologous ATP-binding, and large, multispanning transmembrane …
A Boumendjel, J Boutonnat, J Robert - 2009 - Wiley Online Library
The concept of multidrug resistance (MDR) in tumors originated from the pioneer work of June Biedler in the early 1970s, who identified a wide profile of cross-resistance in Chinese …
The ATP‐binding cassette (ABC) transporter superfamily is one of the largest membrane protein families existing in wide spectrum of organisms from prokaryotes to human. ABC …
S Li, W Zhang, X Yin, S Xing… - Anti-Cancer Agents …, 2015 - ingentaconnect.com
The ABC (ATP-binding cassette) transporter is one of the largest and most ancient protein families with members functioning from protozoa to human. The resistance of cancer and …
ATP-binding cassette (ABC) genes play a role in the resistance of malignant cells to anticancer agents. The ABC gene products, including ABCB1 (P-glycoprotein), ABCC1 …
Background ABC transporters have attracted considerable attention for their function as drug transporters in a broad range of tumours and are therefore considered as major players in …
JI Fletcher, M Haber, MJ Henderson… - Nature Reviews Cancer, 2010 - nature.com
Multidrug transporter proteins are best known for their contributions to chemoresistance through the efflux of anticancer drugs from cancer cells. However, a considerable body of …
O Kadioglu, MEM Saeed, M Munder, A Spuller… - Biomedicine & …, 2020 - Elsevier
ATP-binding cassette (ABC) transporters mediate multidrug resistance in cancer. In contrast to DNA single nucleotide polymorphisms in normal tissues, the role of mutations in tumors is …